ubiquitinylation, allowing translocation of p65/RelA-p50 or c-Rel/p50 heterodimers into the nucleus (Ghosh and Baltimore, 1990; May and Ghosh, 1997) . This phosphorylation is a result of IB-kinase (IKK)  and  activation via IKK/NEMO. An essential adaptor protein linking proximal BCR and T cell receptor (TCR) signaling to activation of the IKK complex, Jun N-terminal kinase (JNK), mTORC1 (mammamlian target of Rapamycin complex 1) and the sodium/glutamine antiporter ASCT2 (encoded by the slc1a15 gene) is CARMA1/CARD11 (Egawa et al., 2003; Hara et al., 2003; Jun et al., 2003) . CARMA1 consists of a CARD-domain, followed by a coiled-coil domain, a linker region, a PDZ and a SH3 domain and a guanylate kinase (GUK)-domain. CARMA1 forms a complex with the CARD containing B cell lymphoma (Bcl) 10 and Mucosa associated lymphoid tissue (MALT) 1, the CBM complex. Hence, null mutations of Bcl10 and MALT1 abrogate antigen receptor induced activation of NF-B, JNK and mTORC1 (reviewed in Lu et al., 2018) . CBM activation in B cells is achieved by phosphorylation of CARMA1 in its linker region by PKC, leading to opening of CARMA1. CARMA1 and Bcl10 interact through their CARD domains. The paracaspase domain of MALT1 interacts with the coiled-coil domain of CARMA1 and the IgG domains of MALT1 bind the Serine/Threonine rich region of Bcl10 (reviewed in Lu et al., 2018; Rawlings et al., 2006) . Antigenic stimulation elicits higher order structures of the CBM complex by virtue of filaments formed by Bcl10. This creates an amplification loop, initiating MALT1 protease activaty as well as canonical NF-κB and JNK signaling. Moreover, MALT1 feeds back on the CBM complex through its protease activity. Further phosphorylation and ubiquitination of BcL10 induces more feedback and feed-forward events within the CBM complex. Thus, BCL10 is a positive and negative integrator of processes that tune the function and destruction of CBM complexes (Gehring et al., 2018) .
While the CBM complex is required for humoral immunity it is also involved in diffuse large B cell lymphomagenesis through somatic gain of function mutations in CARMA1 (Lenz et al., 2008) . In contrast, mutations in the genes encoding the CBM complex cause a variety of inborn immunodeficiencies, the "CBM-opathies" (Lu et al., 2018) .
The CBM mediated signaling pathways towards NF-B and JNK are complex but quite well described. How CARMA1 is linked to mTORC1 controlled protein synthesis is not clear but Bcl10 is not required for this signaling branch (Hamilton et al., 2014; Lu et al., 2018) . We hypothesized that previously not identified proteins interact with CARMA1 in B cells. Here we describe the enrichment of endogenous CARMA1 complexes through antibody affinity chromatography and the identification of three proteins copurified with CARMA1, namely NIBP1, G3BP1 and Tfg. The putative interaction of CARMA1 and Tfg was confirmed by co-immunoprecipitation and Blue Native PAGE.
Results and Discussion
The aim of this project was to identify new components of the lymphocyte specific CARMA1 signalling complex and therefore we chose to purify the endogenous CARMA1 complex through immuno-affinity purification from mouse B lymphoma cells.
We generated two rabbit anti-CARMA1 peptide antibodies (584 and 947), directed against peptides outside the known CARMA1 domains. The affinity-purified antibodies detect murine full-length CARMA1 ectopically expressed in HeLa cells ( Fig. 1a ) as well as degradation product of CARMA1 likely resulting from overexpression ( Fig. 1a ).
Specificity and suitability of the antibodies was confirmed by immunoprecipitation from 2 B cell lines, CH27 and WEHI231 ( Fig. 1b) , followed by excision of the putative CARMA1 band and mass spectrometric confirmation of its identity (Table 1) .
Affinity-purified antibodies 584 and 947 as well as Protein A-purified CARMA1-947preimmune serum were used to immunopurify CARMA1 from lysates of non-activated CH27.LX B cells via antibody affinity chromatography. Western Blot analysis of aliquots of input (In), flowthrough (FT), wash (W) and eluate (E) fractions (5% of each fraction demonstrated that CARMA1 eluted predominantly in fractions E2 and E3 (representative experiment shown in Fig. 1c , upper panel). Aliquots of input and flowthrough (5% of each fraction) and wash fractions along with eluate fractions (90% of the fractions) were further separated by 10% SDS-PAGE and stained with colloidal coomassie blue (representative experiment shown in Fig. 1c , lower panel). This experiment was performed two times with anti CARMA1-947 Sepharose and once with anti CARMA1-584-Sepharose in parallel with IgG-Sepharose (Table 1) . Specific bands compared to the control eluate were cut out and identified by mass spectrometry (Table   1) , revealing CARMA1 itself (p132), the IKK and NIK-binding protein (NIBP; p99), RasGAP-SH3-binding protein 2 (G3BP1, p64) as well as the Trk-fused-gene (p50, Tfg) (specific representative bands are marked in Figure 1d with red arrows, black arrows mark unspecific bands). Only proteins identified independently at least twice with significant cores were considered to be relevant and are marked in bold. Repetition of this experiment with anti BCR (45 min) activated B cells resulted in too many unspecific bands (data not shown). Surprisingly, we did not identify Bcl10 or MALT1 by mass spectrometry in eluates of the anti CARMA1 Sepharose, likely because we focused on distinctive bands. Bcl10 and MALT1 may have been covered by unspecific bands.
NIBP has been shown to support canonical NF-B and JNK activity (Hu et al., 2005; Qin et al., 2017) , G3BP-1 is a Ras-GTPase-activating protein (SH3 domain)-binding protein (also known as Rasputin) belonging to a family of RNA binding proteins that regulate gene expression in response to environmental stresses by controlling mRNA stability and translation (Alam and Kennedy, 2019) . Tfg consists of 397 amino acids structured into an N-terminal PB1 protein-protein-interaction domain (Sumimoto et al., 2007) , a coiled-coil domain and a C-terminal Proline rich domain (Figure 1d ). Tfg has been shown to interact with IKK (Miranda et al., 2006) , promote cell size and oppose apoptosis antagonistic to ced-4/APAF-1 (Chen et al., 2008) , be important for organization of the endoplasmic reticulum (ER; Johnson et al., 2015) and control organization of the ER-Golgi-intermediate compartment (ERGIC; Hanna et al., 2017) .
Moreover, Tfg is also involved in the ubiquitin-proteasome system (UPS; Yagi et al., 2014) and fusions of the tfg gene with other genes can lead to oncogenic fusion proteins that drive lymphomas and leukemias (Chase et al., 2010; Chong et al., 2018; Hernandez et al., 2002; Hernandez et al., 1999; Kim et al., 2016; Witte et al., 2011) .
The intrinsic oligomerization activity of Tfg (Johnson et al., 2015) , its interaction with the IKK complex, its positive effect on cell growth and its structural function in the ER/ERGIC suggested that it could be a functional constituent of the CBM complex, connecting it to IKK or mTORC1 enhanced mRNA translation. Thus, we focused on Tfg.
To test further for an interaction between CARMA1 and Tfg we used CH12 B cells (Bishop and Haughton, 1986) to overexpress either N-terminally (HA-Tfg) or Cterminally (Tfg-HA) HA-tagged Tfg. Conversely, we silenced Tfg expression in CH12 B cells by stable shRNA-interference and we generated specific, affinity-purified anti-Tfg peptide antibodies (Figure 2a ). Using these antibodies we confirmed the presence of Tfg in eluates of the anti CARMA1 584 column by Western Blotting (Figure 2b ). To corroborate the CARMA1-Tfg interaction we immunoprecipitated Tfg from lysates of Tfg-silenced, control or Tfg-overexpressing CH12 cells using our own anti Tfg antiserum ( Figure 2c ). While being present at comparable amounts in the total cell lysate, CARMA1 co-precipitated dose-dependently with Tfg regardless of short term BCR or CD40 stimulation ( Figure 2c ). Long term stimulation may alter the stoichiometry of the Tfg-CARMA1 complex, a possibility that we have not tested here. We noted that still tiny amounts of Tfg as well as CARMA1 were precipitated from CH12 cells with silenced Tfg expression, suggesting that silencing was not 100%. We failed to coimmunoprecipitate CARMA1 with HA-tagged Tfg using anti-HA antibodies in several attempts (data not shown). This may be due to sterical hindrance. Moreover, in our column-based immuno-affinity purification approach the protein concentration in the cell lysate and the avidity of the anti CARMA1 antibody avidity on the affinity matrix were higher than under IP conditions, likely contributing to stabilization of CARMA1 complexes. Lastly, protease activity towards CARMA1 may be associated with Tfg under these conditions, which could be addressed by specific inhibition. (Johnson et al., 2015) . We suggest that in B cells, Tfg is part of a CARMA1 subcomplex of about 600 kDa and that Tfg overexpression induces a 740 kDa complex containing at least CARMA1 and Tfg. In summary, we provide three lines of evidence for an interaction of CARMA1 with Tfg in murine B lymphoma cells: First, identification of Tfg by mass spectrometry and Western Blotting in eluates of anti-CARMA1 Sepharose, second, copurification of CARMA1 with Tfg in anti-Tfg immunoprecipitates and third, a concomitant shift towards higher molecular mass of Tfg and CARMA1 complexes upon Tfg overexpression. It remains to be determined whether there is a direct and functional interaction between Tfg and CARMA1. Due to linkage of the CBM complex to the mTORC1 pathway and the supportive role of Tfg in regulation of cell size and ER function it is tempting to speculate that Tfg is involved in these processes downstream of the BCR via the CBM complex.
Materials and Methods

Transfection
HeLa cells were transfected with full length murine CARMA1 cDNA cloned into pCMVSport6 (obtained from RZPD, Berlin, Germany, clone ID IRAK0961H0B208Q2)
with Lipofectamine (Thermo Fisher) according to standard procedures. CH12 cells (5 x 10 6 ) were electroporated with 10g of cDNA by nucleofection (Solution "R", program "K-005", Amaxa). Single clones were obtained by limiting dilution of cell kept in selection medium (G418, 400 g/ml). N-or C-terminally HA-tagged Tfg cDNAs were generated by PCR using a full length cDNA clone (obtained by RZPD, Berlin, Germany, clone ID IRAKp961H03208Q2) as template with the following primers containing Immunoprecipitation 20 x 10 6 CH27 (Bishop and Haughton, 1986) or WEHI231 (Boyd et al., 1981) 
Blue Native (BN) polyacrylamide gel electrophoresis (PAGE)
BN-PAGE was essentially performed according to previously published procedures (Schägger and von Jagow, 1991) but cell lysates were prepared as follows to avoid dialysis: 40 x 10 6 cells were lysed in 1 ml of buffer containing 1% NP40, 120 mM NaCl, 30 mM NaF, 25 mM Imidazole pH 7.6, 5 mM EDTA, 5 mM 6-aminocaproic acid, 1 mM PMSF, 1 mM NEM, 1 mM Vanadate) for 10 min on ice and centrifuged for 5 min at 5000g. Supernatants were immediately mixed with an equal volume of ice-cold 85% Sucrose in 120 mM NaCl, 30 mM NaF, 25 mM Imidazole pH 7.6. Then, samples were ortho-phosphoric-acid, 10% ammonium sulfate]) overnight. The gels were then soaked several times in 1% acetic acid until background was clear. Bands of interest were cut out in parallel with bands of control gels. Bands were digested with trypsin, peptides were eluted and analyzed by matrix assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry as described previously (Mielenz et al., 2005; Vettermann et al., 2011) (Harlow, 1988) (http://www.pineda-abservice.de/). For antibody affinity purification, peptides were coupled via the cysteines to Sulfo-link resine (Pierce, Rockford, IL) according to the manufacturer's instructions. Antibody purification on peptide columns was performed according to standard procedures (Harlow, 1988) .
Affinity-purified antibodies were used at 0.5-1 g/ml for Western-Blotting. Rat anti-CD40 and anti-B cell receptor antibodies were purified from the IC10 and b.7.6
hybridomas (Julius et al., 1984; Santos-Argumedo et al., 1994) .
SDS-PAGE and Western Blotting
Cells were washed in PBS and lysed in IP lysis buffer (see above). Western Blotting of 12x15cm 2 SDS-PAGE gels was performed according to standard procedures.
Membranes were blocked in 5% skim milk powder in TBST and washed in TBST.
Primary antibodies were diluted in 3% BSA in TBST containing 0.02%NaN3, secondary antibodies were diluted in 5% skim milk powder in TBST. Blots were developed by enhanced chemiluminescence. Antibodies were rabbit Ig anti-CARMA1 and anti-Tfg Summary of protein identification data
